NEXT BIOTECH

What We DO and DON’T like about the proposed CPH Merger

Next Investors Jun 17, 2021

Today Creso Pharma (ASX: CPH | OTC: COPHF) announced its plans to merge with a Canadian listed psychedelics company called Red Light Holland.

CPH’s US listing is happening tonight - trading as OTC: COPHF

Next Investors Jun 11, 2021

Creso Pharma (ASX:CPH) today announced its listing in the US, and the market is opening in around 12 hours - the US pool of investors is huge and they have a big appetite for psychedelics and cannabis stocks.

CPH just picked up 10 grams of pharma grade psilocybin

Next Investors May 14, 2021

Creso Pharma (ASX: CPH)’s acquisition target Halucenex just picked up an extra 10g of ‘hard-to-access’ synthetic psilocybin - and now has 22.3g in total.

The NASDAQ Listing We Will be Watching Tonight

Next Investors Apr 27, 2021

Creso Pharma (ASX: CPH) is listing on the US markets within weeks (via an OTC listing), but a similar company called MindMed is listing on the NASDAQ in 8 hours from now.

We Participated in the CPH placement - and so did Billionaire John Hancock

Next Investors Mar 26, 2021

Creso Pharma (ASX: CPH) is edging closer to becoming part of our long term portfolio. CPH just raised $18M, which significantly shores up the balance sheet - another tick in the box for us as CPH builds trust to enter our long term portfolio.

SURPRISE: We are Now Psychedelics Investors

Next Investors Mar 15, 2021

Once again, medicinal cannabis company Creso Pharma (ASX: CPH) keeps pleasantly surprising us. Today they have REALLY surprised us by announcing they have acquired a Psychedelics company.

CPH to be the First ASX Stock to Acquire 100% of a Psychedelics Company

Next Investors Mar 15, 2021

Creso Pharma (ASX: CPH) will be the first ASX listed stock to acquire 100% of a psychedelics company. CPH is set to acquire Canada based Halucenex Life Sciences Inc., an established psychedelics company developing treatments for a range of mental illnesses.

CPH deliver Financials and Confirms US Cannabis Market Entry

Next Investors Mar 01, 2021

Creso Pharma (ASX: CPH) just released its preliminary financial reports for the year, which as expected show a bunch of impairments, debt clean ups and other scary looking one off costs that come with a balance sheet clean up - these are all out of the way now.

CPH Confirms US Cannabis Market Entry with Established Partner - US$5M Sales Target